CDK4 antibody (AA 2-303) (FITC)
Quick Overview for CDK4 antibody (AA 2-303) (FITC) (ABIN1991942)
Target
See all CDK4 AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    
- 
                                            
Binding Specificity
 - AA 2-303
 - 
                                            
Cross-Reactivity
 - Human
 - 
                                            
Purification
 - >95%, Protein G purified
 - 
                                            
Immunogen
 - Recombinant Human Cyclin-dependent kinase 4 protein (2-303AA)
 - 
                                            
Isotype
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - Optimal working concentration should be determinde by the investigator.
 - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Buffer
 - 
                        Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - 
                                            
Preservative
 - ProClin
 - 
                                            
Precaution of Use
 - This product contains ProClinTM: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
 - 
                                            
Handling Advice
 - Avoid repeated freeze.
 - 
                                            
Storage
 - -20 °C,-80 °C
 - 
                                            
Storage Comment
 - Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
 - 
                                            
 - 
    
- CDK4 (Cyclin-Dependent Kinase 4 (CDK4))
 - 
                                            
Alternative Name
 - CDK4
 - 
                                            
Background
 - 
                        
Background: Ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G1/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G1 phase. Hypophosphorylates RB1 in early G1 phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also phosphorylates SMAD3 in a cell-cycle-dependent manner and represses its transcriptional activity. Component of the ternary complex, cyclin D/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex.
Aliases: Cdk 4 antibody, cdk4 antibody, CDK4 protein antibody, CDK4_HUMAN antibody, Cell division kinase 4 antibody, Cell division protein kinase 4 antibody, CMM 3 antibody, CMM3 antibody, Crk3 antibody, Cyclin dependent kinase 4 antibody, Cyclin-dependent kinase 4 antibody, Melanoma cutaneous malignant 3 antibody, MGC14458 antibody, p34 cdk4 antibody, PSK J3 antibody, PSK-J3 antibody
 - 
                                            
UniProt
 - P11802
 - 
                                            
Pathways
 - Cell Division Cycle, Mitotic G1-G1/S Phases, Regulation of Cell Size
 
Target
 -